OXYPLUS INC has a total of 15 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NORTHWICK PARK INST FOR MEDICA, ANACOR PHARMACEUTICALS INC and HEMOCORM LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Canada | 3 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | China | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Special acyclic compounds | |
#4 | Sugars | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Lehn Jean-Marie | 14 |
#2 | Nicolau Claude | 13 |
#3 | Greferath Ruth | 13 |
#4 | Fylaktakidou Konstantina C | 11 |
#5 | Ruth Greferath | 1 |
#6 | Pothukanuri Srinivasu | 1 |
#7 | Jean-Marie Lehn | 1 |
#8 | Nicolau Yves Claude | 1 |
#9 | Duarte Carolina | 1 |
#10 | Claude Nicolau | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007120484A2 | Use of inositol-tripyrophosphate in treating tumors and diseases | |
CA2601641A1 | Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin |